Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures

Abstract

Deep sequencing of B cell receptor (BCR) heavy chains from a cohort of 31 COVID-19 patients from the UK reveals a stereotypical naive immune response to SARS-CoV-2 which is consistent across patients. Clonal expansion of the B cell population is also observed and may be the result of memory bystander effects. There was a strong convergent sequence signature across patients, and we identified 1,254 clonotypes convergent between at least four of the COVID-19 patients, but not present in healthy controls or individuals following seasonal influenza vaccination. A subset of the convergent clonotypes were homologous to known SARS and SARS-CoV-2 spike protein neutralizing antibodies. Convergence was also demonstrated across wide geographies by comparison of data sets between patients from UK, USA, and China, further validating the disease association and consistency of the stereotypical immune response even at the sequence level. These convergent clonotypes provide a resource to identify potential therapeutic and prophylactic antibodies and demonstrate the potential of BCR profiling as a tool to help understand patient responses.

References 52

1. 1.

   Lu H Stratton CW Tang YW Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol (2020 ) 92:401–2.

   Not in our library10.1002/jmv.25678

2. 2.

   Huang C Wang Y Li X Ren L Zhao J Hu Y Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (2020 ) 395:497–506.

   Not in our library10.1016/s0140-6736(20)30183-5

3. 3.

   Wan Y Shang J Graham R Baric RS Li F Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol (2020 ) 94(7):e00127–20.

   Not in our library10.1128/jvi.00127-20

4. 4.

   Chen N Zhou M Dong X Qu J Gong F Han Y Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (2020 ) 395:507–13.

   Not in our library10.1016/s0140-6736(20)30211-7

5. 5.

   Mulangu S Dodd LE Davey RT Mbaya OT Proschan M Mukadi D A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med (2019 ) 381:2293–303.

   Not in our library10.1056/nejmoa1910993

6. 6.

   Gogtay NJ Munshi R Narayana DHA Mahendra BJ Kshirsagar V Gunale B Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study. Clin Infect Dis (2018 ) 66:387–95.

   Not in our library10.1093/cid/cix791

7. 7.

   Johnson S Oliver C Prince GA Hemming VG Pfarr DS Wang S Development of a Humanized Monoclonal Antibody (MEDI-493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus. J Infect Dis (1997 ) 176:1215–24.

   Not in our library10.1086/514115

8. 8.

   Wang SF Tseng SP Yen CH Yang JY Tsao CH Shen CW Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res Commun (2014 ) 451:208–14.

   Not in our library10.1016/j.bbrc.2014.07.090

9. 9.

   Tetro JA Is COVID-19 receiving ADE from other coronaviruses? Microbes Infect (2020 ) 22:72–3.

   Not in our library10.1016/j.micinf.2020.02.006

10. 10.

    Sharma A It is too soon to attribute ADE to COVID-19. Microbes Infect (2020 ) 22:158.

    Not in our library10.1016/j.micinf.2020.03.005

11. 11.

    Wang Q Zhang L Kuwahara K Li L Liu Z Li T Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect Dis (2016 ) 2:361–76.

    Not in our library10.1021/acsinfecdis.6b00006

12. 12.
    Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability · 2020

    No notice
13. 13.

    Andreano E Nicastri E Paciello I Pileri P Manganaro N Piccini G Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients. bioRxiv (2020 ).

    Not in our library10.1101/2020.05.05.078154

14. 14.

    Robbiani DF Gaebler C Muecksch F Lorenzi JCC Wang Z Cho A Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature (2020 ) 584:437–42.

    Not in our library10.1038/s41586-020-2456-9

15. 15.

    Nielsen SCA Yang F Jackson KJL Hoh RA Röltgen K Jean GH Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host Microbe (2020 ) 28:516–25.e5.

    Not in our library10.1016/j.chom.2020.09.002

16. 16.

    De Mattos-Arruda L Sammut SJ Ross EM Bashford-Rogers R Greenstein E Markus H The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer. Cell Rep (2019 ) 27:2690–708.e10.

    Not in our library10.1016/j.celrep.2019.04.098

17. 17.

    van Dongen JJM Langerak AW Brüggemann M Evans PAS Hummel M Lavender FL Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia (2003 ) 17:2257–317.

    Not in our library10.1038/sj.leu.2403202

18. 18.

    Vander Heiden JA Yaari G Uduman M Stern JNH O’Connor KC Hafler DA pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics (2014 ) 30:1930–2.

    Not in our library10.1093/bioinformatics/btu138

19. 19.

    Gupta NT Vander Heiden JA Uduman M Gadala-Maria D Yaari G Kleinstein SH Change-O: A toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics (2015 ) 31:3356–8.

    Not in our library10.1093/bioinformatics/btv359

20. 20.

    Edgar RC Search and clustering orders of magnitude faster than BLAST. Bioinformatics (2010 ) 26:2460–1.

    Not in our library10.1093/bioinformatics/btq461

21. 21.

    Ye J Ma N Madden TL Ostell JM IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res (2013 ) 41:W34–40.

    Not in our library10.1093/nar/gkt382

22. 22.

    Ghraichy M Galson JD Kovaltsuk A von Niederhäusern V Schmid JP Recher M Maturation of the Human B-Cell Receptor Repertoire with Age. Front Immunol (2020 ) 11:1734.

    Not in our library10.2139/ssrn.3518535

23. 23.

    Tipton CM Fucile CF Darce J Chida A Ichikawa T Gregoretti I Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol (2015 ) 16:755–65.

    Not in our library10.1038/ni.3175

24. 24.

    Gupta NT Adams KD Briggs AW Timberlake SC Vigneault F Kleinstein SH Hierarchical Clustering Can Identify B Cell Clones with High Confidence in Ig Repertoire Sequencing Data. J Immunol (2017 ) 198:2489–99.

    Not in our library10.4049/jimmunol.1601850

25. 25.

    Kovaltsuk A Leem J Kelm S Snowden J Deane CM Krawczyk K Observed Antibody Space: A Resource for Data Mining Next-Generation Sequencing of Antibody Repertoires. J Immunol (2018 ) 201:2502–9.

    Not in our library10.4049/jimmunol.1800708

26. 26.

    Galson JD Clutterbuck EA Trück J Ramasamy MN Münz M Fowler A BCR repertoire sequencing: different patterns of B cell activation after two Meningococcal vaccines. Immunol Cell Biol (2015 ) 93:885–95.

    Not in our library10.1038/icb.2015.57

27. 27.

    Gupta N Vander Heiden J Uduman M Gadala-Maria Heiden D Yaari G Kleinstein S Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics (2015 ) 1–3.

    Not in our library10.1093/bioinformatics/btv359

28. 28.
    A pneumonia outbreak associated with a new coronavirus of probable bat origin · 2020

    No notice
29. 29.

    Bolotin DA Poslavsky S Mitrophanov I Shugay M Mamedov IZ Putintseva EV MiXCR: software for comprehensive adaptive immunity profiling. Nat Methods (2015 ) 12:380–1.

    Not in our library10.1038/nmeth.3364

30. 30.

    Raybould MIJ Kovaltsuk A Marks C Deane CM CoV-AbDab: the coronavirus antibody database. Bioinformatics (2020 ) btaa739.

    Not in our library10.1093/bioinformatics/btaa739

31. 31.
    CD-HIT: accelerated for clustering the next-generation sequencing data · 2012

    No notice
32. 32.

    R Core Team R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing (2008 ). Available at: http://www.r-project.org.

    Not in our library

33. 33.

    Wickham H ggplot2: Elegant Graphics for Data Analysis. 1st ed Springer-Verlag New York: Springer (2009 ). Available at: https://ggplot2.tidyverse.org.

    Not in our library

34. 34.

    Tavakolpour S Rakhshandehroo T Wei EX Rashidian M Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett (2020 ) 225:31–2.

    Not in our library10.1016/j.imlet.2020.06.013

35. 35.

    Pascual V Victor K Lelsz D Spellerberg MB Hamblin TJ Thompson KM Nucleotide sequence analysis of the V regions of two IgM cold agglutinins: Evidence that the V(H)4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol (1991 ) 146:4385–91.

    Not in our library

36. 36.
    Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching · 2016

    Corrected
37. 37.

    Parameswaran P Liu Y Roskin KM Jackson KKL Dixit VP Lee J-Y Convergent Antibody Signatures in Human Dengue. Cell Host Microbe (2013 ) 13:691–700.

    Not in our library10.1016/j.chom.2013.05.008

38. 38.

    Zost SJ Gilchuk P Chen RE Case JB Reidy JX Trivette A Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat Med (2020 ) 26:1422–7.

    Not in our library10.1038/s41591-020-0998-x

39. 39.
    Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model · 2020

    No notice
40. 40.

    Seydoux E Homad LJ MacCamy AJ Parks KR Hurlburt NK Jennewein MF Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual. bioRxiv (2020 ).

    Not in our library10.1101/2020.05.12.091298

41. 41.

    Pinto D Park YJ Beltramello M Walls AC Tortorici MA Bianchi S Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature (2020 ) 583:290–5.

    Not in our library10.1038/s41586-020-2349-y

42. 42.
    A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction · 2020

    No notice
43. 43.

    Wec AZ Haslwanter D Abdiche YN Shehata L Pedreño-Lopez N Moyer CL Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine. Proc Natl Acad Sci USA (2020 ) 117:6675–85.

    Not in our library10.1073/pnas.1921388117

44. 44.

    Tian C Luskin GK Dischert KM Higginbotham JN Shepherd BE Crowe JE Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol (2008 ) 180:3279–88.

    Not in our library10.4049/jimmunol.180.5.3279

45. 45.

    Godoy-Lozano EE Téllez-Sosa J Sánchez-González G Sámano-Sánchez H Aguilar-Salgado A Salinas-Rodríguez A Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response. Genome Med (2016 ) 8:23.

    Not in our library10.1186/s13073-016-0276-1

46. 46.

    Kalinke U Oxenius A López-Macías C Zinkernagel RM Hengartner H Virus neutralization by germ-line vs. hypermutated antibodies. Proc Natl Acad Sci USA (2000 ) 97:10126–31.

    Not in our library10.1073/pnas.97.18.10126

47. 47.

    Wec AZ Wrapp D Herbert AS Maurer D Haslwanter D Sakharkar M Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein. bioRxiv (2020 ).

    Not in our library10.1101/2020.05.15.096511

48. 48.

    Grifoni A Weiskopf D Ramirez SI Mateus J Dan JM Rydyznski Moderbacher R Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell (2020 ) 181(7):1489–501.

    Not in our library10.1016/j.cell.2020.05.015

49. 49.
    Preexisting and de novo humoral immunity to SARS-CoV-2 in humans · 2020

    No notice
50. 50.
    Effectiveness of convalescent plasma therapy in severe COVID-19 patients · 2020

    No notice
51. 51.
    Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures · 2020

    No notice
52. 52.

    Corrie BD Marthandan N Zimonja B Jaglale J Zhou Y Barr E iReceptor: A platform for querying and analyzing antibody/B-cell and T-cell receptor repertoire data across federated repositories. Immunol Rev (2018 ) 284:24–41.

    Not in our library10.1111/imr.12666

Cited by papers we hold 3

• Immunity to SARS‐CoV‐2 induced by infection or vaccination · 2021
  No notice
• Antibody response to SARS-CoV-2 infection in humans: A systematic review · 2020
  No notice
• S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.